Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medicines Co Completes Acquisition Of Incline Therapeutics Inc


Monday, 7 Jan 2013 09:00am EST 

Medicines Co announced that it has completed its acquisition of Incline Therapeutics Inc a company focused on the development of IONSYS (fentanyl iontophoretic transdermal system), a compact, disposable, needleless Patient-Controlled Analgesia (PCA) system in development for the short-term management of acute postoperative pain in the hospital setting. Incline has become a wholly owned subsidiary of The Medicines Company. 

Company Quote

21.85
-1.49 -6.38%
22 Oct 2014